Cited by

• Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function.

  Gallo P, Cupic D, Bracco F, Krzalic L, Tavolato B, Battistin L. Gallo P, et al. Ital J Neurol Sci. 1989 Dec;10(6):561-5. doi: 10.1007/BF02333791. Ital J Neurol Sci. 1989. PMID: 2515167
• Simultaneous visualization of vascular permeability change and leukocyte egress in the central nervous system during autoimmune encephalomyelitis.

  Simmons RD, Buzbee TM, Linthicum DS, Mandy WJ, Chen G, Wang C. Simmons RD, et al. Acta Neuropathol. 1987;74(2):191-3. doi: 10.1007/BF00692851. Acta Neuropathol. 1987. PMID: 3673510
• Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.

  Hertz F, Deghenghi R. Hertz F, et al. Agents Actions. 1985 Jul;16(5):397-403. doi: 10.1007/BF01982879. Agents Actions. 1985. PMID: 2413742
• In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

  Sorensen O, Coulter-Mackie MB, Puchalski S, Dales S. Sorensen O, et al. Virology. 1984 Sep;137(2):347-57. doi: 10.1016/0042-6822(84)90227-7. Virology. 1984. PMID: 6091333 Free PMC article.
• The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease.

  Paterson PY, Gausas J, Koh CS, Kwaan HC. Paterson PY, et al. Trans Am Clin Climatol Assoc. 1986;97:149-57. Trans Am Clin Climatol Assoc. 1986. PMID: 3879817 Free PMC article. No abstract available.